New ADCs: HER2 and Beyond
ADCs with Alternative HER2 Targeting Mechanisms and Beyond HER2-Positive Disease: Expanding Potential Benefit to Other Breast Cancer Subsets

Released: October 30, 2020

Activity

Progress
1
Course Completed